Cargando…
Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation
Bivalirudin, an IV direct thrombin inhibitor, and unfractionated heparin (UFH) are frequently used anticoagulants in the pediatric critical care setting. An accurate, specific, point-of-care test to quantify and detect anticoagulation resistance is not currently available. This study evaluates the a...
Autores principales: | Frydman, Galit H., Berger, Barry M., Kostousov, Vadim, Bruzdovski, Karen, Papageorgiou, Dimitrios P., Navaei, Amir, Hui, Shiu-Ki Rocky, Teruya, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605743/ https://www.ncbi.nlm.nih.gov/pubmed/36311559 http://dx.doi.org/10.1097/CCE.0000000000000776 |
Ejemplares similares
-
Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023) -
Coagulation and Bleeding Management in Pediatric Extracorporeal Membrane Oxygenation: Clinical Scenarios and Review
por: Hensch, Lisa A., et al.
Publicado: (2019) -
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
por: Frydman, Galit H., et al.
Publicado: (2020) -
Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood
por: Luna, David J., et al.
Publicado: (2020) -
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)